Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Embryo Implantation | 5 | 2017 | 230 | 0.800 |
Why?
|
| Fertilization in Vitro | 6 | 2017 | 188 | 0.730 |
Why?
|
| Endometrium | 3 | 2017 | 276 | 0.700 |
Why?
|
| Infertility, Female | 3 | 2017 | 165 | 0.660 |
Why?
|
| Embryo Transfer | 3 | 2017 | 82 | 0.600 |
Why?
|
| Sex Preselection | 1 | 2012 | 7 | 0.400 |
Why?
|
| Ethics, Medical | 1 | 2012 | 395 | 0.320 |
Why?
|
| Transcriptome | 3 | 2017 | 907 | 0.270 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 359 | 0.240 |
Why?
|
| Menstrual Cycle | 2 | 2017 | 35 | 0.230 |
Why?
|
| Diabetes Mellitus, Experimental | 4 | 1991 | 137 | 0.210 |
Why?
|
| Uterus | 6 | 2017 | 594 | 0.200 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2017 | 906 | 0.190 |
Why?
|
| Pregnancy | 11 | 2017 | 7105 | 0.190 |
Why?
|
| Polycystic Ovary Syndrome | 3 | 2016 | 58 | 0.170 |
Why?
|
| Diet, Protein-Restricted | 1 | 2019 | 82 | 0.150 |
Why?
|
| Pregnancy, Animal | 1 | 2017 | 73 | 0.140 |
Why?
|
| Leiomyoma | 2 | 2017 | 90 | 0.140 |
Why?
|
| Oocytes | 1 | 2019 | 290 | 0.140 |
Why?
|
| Progesterone | 2 | 2017 | 624 | 0.140 |
Why?
|
| Uterine Neoplasms | 2 | 2017 | 118 | 0.140 |
Why?
|
| Follicular Fluid | 1 | 2016 | 8 | 0.140 |
Why?
|
| Luteal Cells | 1 | 2016 | 9 | 0.130 |
Why?
|
| Folic Acid | 1 | 2019 | 292 | 0.130 |
Why?
|
| Treatment Failure | 1 | 2017 | 338 | 0.130 |
Why?
|
| Amino Acids | 1 | 2019 | 651 | 0.130 |
Why?
|
| Forecasting | 1 | 2017 | 355 | 0.130 |
Why?
|
| Adrenal Glands | 3 | 1991 | 41 | 0.120 |
Why?
|
| Fertility | 1 | 2016 | 261 | 0.120 |
Why?
|
| Insulin | 5 | 1993 | 1189 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 549 | 0.110 |
Why?
|
| Mitochondria | 1 | 2019 | 681 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 1991 | 65 | 0.110 |
Why?
|
| Recurrence | 1 | 2017 | 1418 | 0.110 |
Why?
|
| Female | 24 | 2019 | 65117 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2016 | 1469 | 0.110 |
Why?
|
| Glucose Tolerance Test | 3 | 1993 | 203 | 0.100 |
Why?
|
| Preimplantation Diagnosis | 1 | 2012 | 21 | 0.100 |
Why?
|
| Social Values | 1 | 2012 | 47 | 0.100 |
Why?
|
| Estradiol | 2 | 1991 | 534 | 0.100 |
Why?
|
| Endometriosis | 2 | 1995 | 185 | 0.100 |
Why?
|
| Reproduction | 2 | 1991 | 237 | 0.090 |
Why?
|
| Ultrasonography | 3 | 1984 | 944 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 1872 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2012 | 804 | 0.080 |
Why?
|
| Inflammation | 1 | 2016 | 1398 | 0.080 |
Why?
|
| Genomics | 1 | 2016 | 1471 | 0.080 |
Why?
|
| Animals | 9 | 2019 | 33618 | 0.080 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 439 | 0.080 |
Why?
|
| Ovary | 2 | 1991 | 389 | 0.080 |
Why?
|
| Blastocyst | 2 | 1998 | 76 | 0.080 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 426 | 0.080 |
Why?
|
| Vagina | 3 | 1984 | 202 | 0.070 |
Why?
|
| Cervix Uteri | 3 | 1984 | 70 | 0.070 |
Why?
|
| Follicular Phase | 3 | 2019 | 17 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2012 | 639 | 0.070 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 1670 | 0.060 |
Why?
|
| Leuprolide | 3 | 1995 | 25 | 0.060 |
Why?
|
| Obesity | 1 | 2016 | 2091 | 0.060 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2017 | 515 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2017 | 2815 | 0.060 |
Why?
|
| Genitalia, Female | 1 | 1984 | 48 | 0.060 |
Why?
|
| Rats, Inbred Strains | 4 | 1991 | 224 | 0.060 |
Why?
|
| Humans | 17 | 2017 | 122633 | 0.060 |
Why?
|
| Ovariectomy | 2 | 1991 | 181 | 0.050 |
Why?
|
| Estrus | 2 | 1990 | 14 | 0.040 |
Why?
|
| Luteinizing Hormone | 2 | 1991 | 119 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2016 | 3256 | 0.040 |
Why?
|
| Cumulus Cells | 1 | 2019 | 43 | 0.040 |
Why?
|
| Zygote | 1 | 1998 | 25 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2012 | 8064 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2019 | 119 | 0.040 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 41 | 0.040 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 132 | 0.040 |
Why?
|
| Insemination | 1 | 1997 | 2 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 4323 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2019 | 358 | 0.040 |
Why?
|
| Role | 1 | 2017 | 26 | 0.040 |
Why?
|
| Prospective Studies | 3 | 2016 | 6012 | 0.040 |
Why?
|
| Rats | 4 | 1991 | 3620 | 0.040 |
Why?
|
| Spain | 1 | 2016 | 53 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 230 | 0.030 |
Why?
|
| Kinetics | 1 | 2019 | 1313 | 0.030 |
Why?
|
| United States | 1 | 2012 | 10559 | 0.030 |
Why?
|
| California | 1 | 2016 | 128 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 160 | 0.030 |
Why?
|
| Species Specificity | 1 | 2017 | 547 | 0.030 |
Why?
|
| Chemokines | 1 | 2016 | 137 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2016 | 85 | 0.030 |
Why?
|
| Danazol | 1 | 1995 | 1 | 0.030 |
Why?
|
| Embryonic Development | 1 | 2017 | 208 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2017 | 1102 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 594 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 1993 | 252 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 353 | 0.030 |
Why?
|
| Gene Expression | 1 | 2019 | 1568 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 1991 | 88 | 0.030 |
Why?
|
| Corticosterone | 2 | 1991 | 60 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 1334 | 0.030 |
Why?
|
| Hyperandrogenism | 1 | 1993 | 19 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1684 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2017 | 611 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 1293 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 592 | 0.030 |
Why?
|
| Adult | 6 | 2016 | 28881 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 1991 | 84 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 2024 | 0.020 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1990 | 8 | 0.020 |
Why?
|
| Cytokines | 1 | 2016 | 1280 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 3047 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2306 | 0.020 |
Why?
|
| Somatomedins | 1 | 1990 | 36 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 1990 | 36 | 0.020 |
Why?
|
| Hypothalamus | 1 | 1991 | 214 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1990 | 185 | 0.020 |
Why?
|
| Pregnancy Complications | 2 | 1984 | 502 | 0.020 |
Why?
|
| Androgens | 1 | 1991 | 256 | 0.020 |
Why?
|
| Male | 3 | 2012 | 59714 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 1993 | 634 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3541 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1990 | 338 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2528 | 0.020 |
Why?
|
| Hysterosalpingography | 2 | 1984 | 12 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 2935 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4200 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2016 | 5019 | 0.020 |
Why?
|
| Glucose | 1 | 1991 | 867 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3079 | 0.020 |
Why?
|
| Abortion, Therapeutic | 1 | 1984 | 4 | 0.010 |
Why?
|
| Hymen | 1 | 1984 | 12 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1984 | 258 | 0.010 |
Why?
|
| Uterine Hemorrhage | 1 | 1984 | 47 | 0.010 |
Why?
|
| Pregnancy, Ectopic | 1 | 1984 | 29 | 0.010 |
Why?
|
| Labor, Obstetric | 1 | 1984 | 95 | 0.010 |
Why?
|
| Testosterone | 3 | 1993 | 462 | 0.010 |
Why?
|
| Liver | 1 | 1990 | 1725 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 9943 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12055 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 17430 | 0.010 |
Why?
|
| Reproductive Techniques | 1 | 1998 | 10 | 0.010 |
Why?
|
| Microinjections | 1 | 1998 | 52 | 0.010 |
Why?
|
| Pregnancy Rate | 1 | 1998 | 48 | 0.010 |
Why?
|
| Abnormalities, Multiple | 1 | 1984 | 964 | 0.010 |
Why?
|
| Injections | 1 | 1997 | 152 | 0.010 |
Why?
|
| Probability | 1 | 1997 | 319 | 0.010 |
Why?
|
| Time Factors | 2 | 1998 | 6188 | 0.010 |
Why?
|
| Spermatozoa | 1 | 1997 | 231 | 0.010 |
Why?
|
| Tissue Adhesions | 1 | 1995 | 29 | 0.010 |
Why?
|
| Laparotomy | 1 | 1995 | 135 | 0.010 |
Why?
|
| Retrospective Studies | 3 | 1998 | 15916 | 0.010 |
Why?
|
| Fructosamine | 1 | 1991 | 6 | 0.010 |
Why?
|
| Hexosamines | 1 | 1991 | 17 | 0.010 |
Why?
|
| Reoperation | 1 | 1995 | 813 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1991 | 58 | 0.010 |
Why?
|
| Dehydroepiandrosterone | 1 | 1991 | 16 | 0.010 |
Why?
|
| Luteal Phase | 1 | 1991 | 10 | 0.010 |
Why?
|
| Spironolactone | 1 | 1991 | 18 | 0.010 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 1991 | 17 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1991 | 214 | 0.010 |
Why?
|
| Ovulation | 1 | 1991 | 112 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1990 | 109 | 0.010 |
Why?
|
| Hormones | 1 | 1991 | 188 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1990 | 396 | 0.010 |
Why?
|
| Laparoscopy | 1 | 1995 | 501 | 0.010 |
Why?
|
| Organ Size | 1 | 1990 | 411 | 0.010 |
Why?
|
| Reference Values | 1 | 1990 | 694 | 0.000 |
Why?
|
| Adolescent | 1 | 1983 | 18987 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1984 | 89 | 0.000 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 1984 | 61 | 0.000 |
Why?
|
| Congenital Abnormalities | 1 | 1984 | 242 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1984 | 320 | 0.000 |
Why?
|
| Prenatal Diagnosis | 1 | 1984 | 579 | 0.000 |
Why?
|